Lung Cancer
Lung Cancer
Rob DillardNon-Small Cell Lung Cancer | September 26, 2023
Researchers have found a link between social determinants of health and survival outcomes in patients with NSCLC.
Read More
Rob DillardLung Cancer | September 19, 2023
Following new protocols allows for many lung cancer patients to leave the hospital 1 day after surgery.
Patrick DalyLung Cancer | September 19, 2023
Early menopause, shortened reproductive span, and other reproductive factors were linked to risk of lung cancer in women.
Rob DillardNon-Small Cell Lung Cancer | September 19, 2023
The combination of durvalumab plus concurrent radiotherapy shows promising in treating NSCLC.
Rob DillardLung Adenocarcinoma | September 17, 2023
Three patient case reports showed that osimertinib is a promising and viable treatment option for lung cancer with bone mets.
Rob DillardNon-Small Cell Lung Cancer | September 17, 2023
A study assessed the link between osimertinib and VEGF expression in patients with advanced non-small cell lung cancer.
Rob DillardNon-Small Cell Lung Cancer | September 17, 2023
Osimertinib treatment was safe and effective in patients with advanced small-cell lung cancer treated amid the pandemic.
Healthcare UnfilteredHealthcare Unfiltered | September 12, 2023
The panel uses the ADAURA trial as a springboard to address clinical trial designs.
Oncology BrothersOncology Brothers | August 25, 2023
Jill Feldman, a lung cancer survivor and co-founder of the EGFR Resisters advocacy group, details her lung cancer journey.
Patrick DalyNon-Small Cell Lung Cancer | August 21, 2023
JK5G postbiotics may improve gut microbiota, QOL, and appetite in patients with advanced NSCLC on PD-1 inhibitor therapy.
Rob DillardASCO 2023 | June 7, 2023
Researchers used a radiomics approach to predict brain metastases in lung cancer patients.
Oncology BrothersOncology Brothers | June 5, 2023
The Oncology Brothers discuss findings from the phase 3 ADAURA trial.
Dr. Patrick FordeASCO 2023 | June 5, 2023
Dr. Patrick Forde spoke with DocWire News at ASCO 2023 about updated data from the CheckMate 816 trial.
Oncology BrothersOncology Brothers | May 1, 2023
The Oncology Brothers highlight three studies from the recent American Association for Cancer Research (AACR) 2023 ...
The Fellow on CallThe Fellow on Call | April 11, 2023
The group makes the distinction between non-small cell lung cancer, used as an umbrella term, and small cell lung cancer.
Patrick DalyNon-Small Cell Lung Cancer | April 5, 2023
In a recent study, published in Thoracic Cancer, researchers evaluated the safety and efficacy of osimertinib plus ...
Patrick DalyNon-Small Cell Lung Cancer | March 31, 2023
In a recent meta-analysis, published in Cancer, researchers evaluated neoadjuvant immunotherapy in patients with ...
Oncology BrothersOncology Brothers | March 28, 2023
In this episode, the Oncology Brothers speak with world-renowned thoracic oncologist Dr. Jarushka Naidoo of Royal ...
The Fellow on CallThe Fellow on Call | March 27, 2023
Lung cancer is one of the most common and deadly malignancies found in oncology, making early detection critical.
The Fellow on CallThe Fellow on Call | March 27, 2023
The third episode in this series answers: What do you do when performing a biopsy on a suspected metastatic lesion?
Latest News

September 29, 2023